DDI.SecondLine-TasP
Kobus Herbst
Joseph Larmarange
Jaco Dreyer
2015-11-13
NADA
1.0.0
Concept sheet - Second line treatment
TasP
Concept Sheet Second line Treatment - TasP
SecondlineTasP
Africa Centre for Health and Population Studies
NADA
Agence Nationale de Recherche sur le Sida et les hépatites virales
Deutsche Gesellschaft für Internationale Zusammenarbeit
MERCK & Co. Inc and Gilead Sciences
Wellcome Trust
International Initiative for Impact Evaluation
Dami Collier
1.0.0
South Africa
Twenty Two survey clusters located in Hlabisa sub-district, Umkhanyakude district, of northern KwaZulu-Natal, South
Africa.
The Hlabisa health sub-district is a rural setting of 1 430 km2 in size, with a population of approximately 220 000 Zuluspeaking
people of whom 3.3% are located in a formal urban township (KwaMsane), 19.9% in peri-urban areas and the
Treatment as Prevention ANRS 12249 - Overview
- 8 -
remainder (76.8%) classified as living in a rural area. The rural population lives in scattered homesteads that are not
concentrated into villages or compounds (as would be the case in many other parts of Africa).
CHE
Clinical History and Examination forms
2015
13
ClinicVisits
Clinic visits
2960
8
DrugPrescriptions
Drug prescriptions
1460
9
PositiveHHMembers
Other Positive household members?
125
6
HIVDrugTreatment
Antiretroviral drug treatment
2394
17
TestResults
Lab Test Results
1393
8
ExitFormDetails
Exit Form Details
125
20
Base file
Base file
121
24
SCI-CFU
Social Science amd Clinical Follow Up
136
15
Individual identifier
121
272
27386
12603.727
7992.42
Cluster Type (arm)
120
Control
Intervent
Sex
121
FEM
MAL
Date of birth
121
1915-04-26
1998-06-24
Start date of secondline
121
2000-07-09
2015-05-28
IQ visit date
94
2012-04-30
2015-11-04
Current marital status
94
Engaged
Married (monogamous)
Married (polygamous)
Missing
Never been married
Widowed
Currently in employment
94
No, not employed
Yes, full-time
Yes, part-time
Highest level of education
94
Completed Primary
Completed Secondary
Deprecated (in IQ1/3, not IQ2)
Higher
None
Some Secondary
Some primary
Household identifier
84
37
194
10483
3966.524
2488.043
Household visit date
84
2012-04-11
2015-06-17
Has fridge or freezer
84
No
Yes
Is resident of household
84
No
Yes
Distance in km to nearest
DoH clinic
7
114
1.985
7.542
6.059
2.03
11
..
Distance in km to nearest
TasP clinic
7
114
1.171
2.712
1.676
0.631
11
..
Distance in km to N2 (level-1
road)
7
114
0.191
3.698
1.496
1.342
101
..
Assets Score
84
37
-1.539
2.596
-0.0812
0.938
11
..
Assets Score Category
84
high
low
middle
CBC visit date
111
2012-04-03
2015-05-20
Date of HIV Diagnosis
111
1993-06-18
2014-11-09
Currently on ART
111
No
Yes
Currently on ART - ART
provider
111
Hlabisa programme
Missing
Not applicable
Other
Currently on ART - ART
provider, Hlabisa clinic
111
Hlabisa wards/staff
Macabuzela
Madwaleni
Makhowe
Missing
Mtubatuba
Nkundusi
Not applicable
Ntondweni
Philanjalo (Hlabisa)
Somkhele
kwaMsane
Currently on ART - ART
111
Charls James ((Durban )
GP Doctor
Madwaleni Clinic
Mandeni
Mduku
Not applicable
Nsingweni
Phongola Clinic
Individual identifier
2015
272
27386
11983.5
7608.985
Cluster Type (arm)
2000
Control
Intervent
Sex
2015
FEM
MAL
Date of birth
2015
1915-04-26
1998-06-24
Start date of secondline
2015
2000-07-09
2015-05-28
Visit identifier
2015
1565
174888
67192.73
43590.624
CHE visit date
2015
2012-06-18
2015-11-13
Current TB treatment
(CurrTB)
2015
Missing
No
Yes
Date treatment started (as
collected, U means unknown,
CurrTB)
49
Date treatment started
(CurrTB)
49
1966
1474070400000
1750550400000
1696677355102.04
36561678417.42
10000000000001
..
Drug regimen (CurrTB)
2015
MDR
Missing
Not applicable
Regimen 1
Regimen 2
WHO Stage
2015
Missing
Stage 1
Stage 2
Stage 3
Stage 4
TB Site (CurrTB)
2015
EPTB
Missing
Not applicable
Smear+ PTB
Smear- PTB
Individual identifier
2960
272
27386
11904.288
7801.196
Cluster Type (arm)
2936
Control
Intervent
Sex
2960
FEM
MAL
Date of birth
2960
1915-04-26
1998-06-24
Start date of secondline
2960
2000-07-09
2015-05-28
Visit date
2960
2012-04-03
2015-11-25
Location identifier
2960
607
21978
7505.14
5374.617
Visit type
2960
Regular
1
Tracking
10
Clinic, Protocol 10wk
11
Clinic, Protocol 14wk
12
Clinic, Protocol 18wk
13
Clinic, Protocol 22wk
14
Clinic, Protocol 26wk
15
Clinic, Protocol 30wk
16
Clinic, Protocol 34wk
17
Clinic, Protocol 38wk
18
Clinic, Protocol 42wk
19
Clinic, Protocol 46wk
2
Futile Field
20
Clinic, Protocol 50wk
21
Clinic, Protocol 54wk
22
Clinic, Protocol 58wk
23
Clinic, Protocol 62wk
24
Clinic, Protocol 66wk
25
Clinic, Protocol 70wk
26
Clinic, Protocol 74wk
27
Clinic, Protocol 78wk
28
Clinic, Protocol 82wk
29
Clinic, Protocol 86wks
3
Futile Tracking
30
Clinic Protocol 90wk
31
Clinic Protocol 94wk
32
Clinic Protocol 98wk
33
Clinic Protocol 102wk
34
Clinic Protocol 106wk
35
Clinic Protocol 110wk
36
Clinic Protocol 114wk
37
Clinic Protocol 118wk
38
Clinic Protocol 122wk
39
Clinic Protocol 126wk
4
CLO Visit (re Refusals)
40
Clinic Protocol 130wk
41
Clinic Protocol 134wk
42
Clinic Protocol 138wk
43
Clinic Protocol 142wk
44
Clinic Protocol 146wk
45
Clinic Protocol 150wk
46
Clinic Protocol 154wk
47
Clinic Protocol 158wk
48
Clinic Protocol 162wk
49
Clinic Protocol 166wk
5
Clinic, Protocol, Baseline
50
Clinic Protocol 170wk
6
Clinic, Non-protocol
7
Clinic, Protocol 2wk
8
Clinic, Protocol 4wk
9
Clinic, Protocol 6wk
99
Missing
Individual identifier
1460
272
27386
11514.99
7874.41
Cluster Type (arm)
1448
Control
Intervent
Sex
1460
FEM
MAL
Date of birth
1460
1915-04-26
1998-06-24
Start date of secondline
1460
2000-07-09
2015-05-28
Drug name
1440
Aciclovir
Allergex(Chlorphenamine/Piriton)
Amethocaine cream
Amitriptyline
Amlodipine
Amoxycillin (Moxypen )
Amphotericin
Aqueous cream
Aspirin
Asthavent (salbutamol) spray
Atenolol
Azithromycin
Benzathine Benzylpenicillin (Peni Lente)
Benzyl Benzoate lotion
Betadine ointment
Bicillin (Penicillin G Benzathine injection)-
Biltricide (Praziquantel)
Brufen/Ibuprofen(Inza)
Buscopan(Hyoscine Butyl bromide)
Calamine Lotion
Calcium
Canesten Vaginal Tab
Cefixime
Ceftriaxone
Chloramex/Chloramphenicol eye ointment
Ciprofloxacin (Ciprobay)
Cocillana (Cough syrup)
Cotrimoxazole
Diphenhydramine hydrochloride
Doxyclycline
Enalapril
Epilim, Sodium Valproate
Erthromycin
FeSO4
Ferrous Fumarate
Ferrous sulphate
Flucloxacillin (Flupen)
Folic Acid (Folate)
Gastrolyte (oral rehydration solution)
HCT (Hydrochlorothiazide)
Haloperidol
Hydrocortisone
Iliadin spray (Oxymetazoline)
Innospore(Clotrimozole)
Isoniazid (INH)
Loperamide
Mebendazole(Wormstop)
Medroxyprogesterone (Depo ? provera)
Metformin
Methy Salicyciate
Metoclopramide
Metronidazole(Flagyl)
Nystatin(Nystacid drops)
Panado
Paracetamol
Penicillin V
Petogen (Medroxyprogesterone acetate)
Phenytoin
Prednisone
Pregamol (Ferrous Fumarate + Folic acid)
Pyridoxine
Selsun shampoo
Sorol
Spersallerg
Sulphasalazine
Tranexamic Acid
Vitamin A (e.g. BCO)
Date prescribed
1440
2012-04-02
2015-11-10
Dose and frequency
1440
0/1 tab dailly
1 T P-O daily
1 TAB DLY
1 TAB DLY
1 Tab DLY
1 Tab dly p.o
1 cap 2 time
1 capsule three times daily
1 daily
1 day
1 dly
1 g -8 hourly
1 g 4 hourly P.R orally
1 g 4-6 hrly orally
1 g 4-6wly orally
1 g 5hrly
1 g 8 hourly
1 g orally 4-6 hourly PRN
1 g p-o prn
1 g p.o prn
1 g p.o. daily
1 g p.o.prn
1 g po prn
1 g prn
1 g shrly
1 g stats
1 g tds / prn
1 g tds prn
1 nocte
1 taab dly
1 tab
1 tab Dly
1 tab daily
1 tab dly
1 tab dly po
1 tab stas
1 tab 12 hrly orally
1 tab 6 hrly orally
1 tab BD
1 tab DLY
1 tab Dly
1 tab QID p-o
1 tab after each loose stool
1 tab after each stool
1 tab bd
1 tab bd po
1 tab daily
1 tab daily 28
1 tab daily orally
1 tab daily p-o
1 tab daily p.o.
1 tab daily po
1 tab db
1 tab dly
1 tab dly nocte
1 tab dly p-o
1 tab dly p.o
1 tab dly p.o.
1 tab dly po
1 tab immediately
1 tab immidiately
1 tab nocte
1 tab oral dldy
1 tab oral dly
1 tab orally rds
1 tab p-o dailly
1 tab p-o daily
1 tab p. o. daily
1 tab p.o daily
1 tab p.o daily
1 tab p.o. Daily
1 tab p.o. daily
1 tab per daily
1 tab po
1 tab po daily
1 tab po nocte
1 tab shrtly
1 tab tds
1 tab tds p-o
1 tab tds po
1 tabafter each loose stool
1 tablet daily
1 tablet daily orally
1 tablets 8hrly PRN for 5days
1 tablets daily orally
1 tablets daily oraly
1 tablets orally daily
1 tablets start then 1 after loose
1 tb dly
1 tds p-o
1 tube apply bd
1 vag tab nocte
1 week p.o.
1% apply
1/1 daily
1/1 dly p.o
1/1 dly po
1/1 nocte orally
1/1 prn
1/1 tab dly
1/2 dly
1/2 start
1/2 tds p.o
10 % cream 20 g apply
10 mg 8-hourly for
10 mg daily
10 mg dly
10 mg dly orally
10 mg on
10 mg p.o prn
10 mg po daily
10 mg po dly
10 ml 8 hrly
10 ml prn
100 mg 12 hourly orally
100 mg 12hrly
100 mg b.d. p.o.
100 mg bd
100 mg bd orally
100 mg daily orally
100 mg dly
100 mg p.o
100 mg po twice
100 mg twice orally
100 orally daily
100mg bd
100mg bd
100mg 12 hourly
100mg 6hrly
100mg bd
100mg bd po
100mg daily
100mg daily p.o
100mg dly
100mg twice
100mg twice daily
100mg twice orally
10mg
10mg dly
10mg dly p.o
10mg 12 hrly
10mg 12hrly
10mg 8 hrly
10mg 8 hrly orally
10mg 8hourly PRN
10mg 8hourly orally PRN
10mg bd
10mg bd p-o
10mg daily
10mg daily for 3days
10mg dly
10mg dly orally
10mg dly p.o
10mg p.o three times
10mg p.o. daily
10mg po dly
10mg prn
10mg tds
10mgdly
10ml 6hrly
10ml 8 hourly
10ml 8 hourly orally
10ml 8 hrly
10ml 8 hrly orally
10ml 8hrly orally
10ml p-o tds
10ml prn
10ml tds
10ml three times daily orally
10mls 6hrly orally
10mls prn
10mls tds p.o
11 taps p.o pm
11/118 hrly p.o
12,5mg
12,5mg daily
12,5mg daily orally
12,5mg dly
12.5 daily p.o.
12.5 g p.o. daily
12.5 mg
12.5 mg daily
12.5 mg daily orally
12.5 mg day
12.5 mg dly
12.5 mg dly orally
12.5 mg oral daily
12.5 mg po daily
12.5 mg po dly
12.5m dly
12.5mg
12.5mg 1 tab dly
12.5mg dly
12.5mg dly orally
12.5mg dly orally
12.5mg daily
12.5mg daly
12.5mg dly
12.5mg dly p.o
12.5mg dly po
12.5mg od
12.5mg oral daily
12.5mg po dly
12.5mgdly
121 5mg dly
150 dly
150 imi
150 mg
150 mg 1 ml
150 mg imi
150 mg imi start
150 mg imi stats
150 mg single dose
1500 mg dly
150mg IMI
150mg daily orally
150mg dly
150mg imi stat
150mg imi stat
19 poprn
1g 4-6hrly orally P.R.N
1g 8hrly
1g p.o prn
1g 4 - 6hrly p.o
1g 4-6 hourly PRN
1g 4-6 hourly orally prn
1g 4-6 hrly orally
1g 4-6hrly
1g 4-6hrly orally
1g 4-6hrly orally
1g 4-6hrly orally P.R.N
1g 4-6hrly orally P.R.N.
1g 8 hourly
1g 8 hrly
1g 8hourly
1g 8hrly
1g 8hrly orally
1g 8hrly po P.R.N
1g 8rhly
1g TDS
1g bd
1g daily
1g dly p.o
1g hrly
1g intramuscular stat
1g oral 6 hourly
1g oral 6hourly
1g p-o prn
1g p-o stat
1g p-o tds
1g p.o prn
1g p.o 8b hourly
1g po 8 hrly
1g prn
1g stat
1g statsimi
1g tds
1g tds / pm
1g tds / prn
1tab
1tab daily
1tab daily orally
1tab dly
1tab twice p.o daily
1tab 3times a day
1tab 4times a day
1tab BD
1tab TDS
1tab after each loose stool
1tab at night
1tab before takin ART /prn
1tab dailly.
1tab daily
1tab daily orally
1tab daily p.o
1tab daily po
1tab dly
1tab dly p.o
1tab dly po
1tab if required
1tab orally daily
1tab p.o daily
1tab p.o nocle
1tab p.o daily
1tab p.o nocte
1tab p.o three times
1tab po daily
1tab tds
1tab tds p.o
1tab tds p.o prn
1tab twice daily
1tabdly
1tablet daily orally
1tablet daily orally
1tablets daily orally
1tabs daily
1tabs dly
2 Tablets daily orally
2 ab daily orally
2 bd
2 daily
2 daily orally
2 dldy
2 dly
2 dly p.o.
2 drops twice
2 g immediately
2 g start p.o.
2 g stat orally
2 manne 3ncte
2 mg PRN
2 prn
2 puffs QiD
2 sachet
2 tab
2 tab 8hrly
2 tab Dly
2 tab QID po
2 tab b.d.
2 tab daily
2 tab daily orally
2 tab daly orally
2 tab dly
2 tab dly p-o
2 tab dly po
2 tab od po
2 tab po daily
2 tab po dily
2 tab po stat
2 tab prn
2 tab tds po
2 tab tds prn
2 tablet daily orally
2 tablets daily orally
2 tablets orally daily
2 tabs
2 tabs TDS p.o
2 tabs dly
2 tabs Dly
2 tabs P.R.N.
2 tabs bd
2 tabs daily
2 tabs daily orally
2 tabs daily oraly
2 tabs daily p-o
2 tabs dly
2 tabs dly p-o
2 tabs dly po
2 tabs orally 2 times
2 tabs orally when necessary
2 tabs p-o daily
2 tabs p-o tds
2 tabs p.o daily
2 tabs p.o.
2 tabs p.o. daily
2 tabs p.o.dly
2 tabs po
2 tabs prn
2 tabs start then 2 mg after each lose stool
2 tabs stat p.o
2 tabs tds
2 tabs tds p-o prn
2 tbs dly
2 tds po
200 mg 6hrly orally
200 mg 8 hourly
200 mg hrly orally
200 mg tds
200mg dly
200mg 3 times
200mg 8 hourly
200mg 8hrlly
200mg 8hrly orally
200mg TDS
200mg tds
200mg tds 3 times
200mg three times daily
200mg twice daily
20g Prn
24muimi
25 dly
25 mg p.o daily
25 mg p.o. daily
25 mg daily
25 mg daily orally
25 mg daily p.o.
25 mg dly
25 mg orally
25 mg p. daily
25 mg p.o daily
25 mg p.o daily
25 mg p.o. daily
25 mgb daily
250 mg imi d
250 mg imi start
250 mg imi stat
250 mg start dose
250mg imi
250mg imi start
250mg stat
25mg
25mg dly
25mg nocte
25mg p.o daily
25mg daily
25mg daily orally
25mg daily p-o
25mg dly
25mg dly p.o
25mg dly p.o
25mg mgnocte
25mg nocte
25mg oral at night
25mg p-o daily
25mg p.o daily
25mg po daily
2TAB DLY 1 TAB
2TABS DLY
2Tab Dly
2dly
2drops 12hourly
2g p.o .stat p.o.
2g sd
2g start
2g stat
2g stat dose
2g stat orally
2g stat p-o
2g stat po
2g stats orally
2mg stat
2mg after each loose stool
2mg after lose stool
2mg daily orally
2mg immediately
2mg p.o.daily
2mg prn
2mg when necessary
2prn
2satelets (1L daily)
2tab dly
2tab p.o daily
2tablet daily orally
2tablets daily orally
2tablets daily korally
2tablets daily orally
2tablets dly orally
2tablets stat orally
2tablets stat then 1 tablets after each loose stool
2tabs
2tabs daily
2tabs dly
2tabs dly p.o
2tabs 5hrly then 1
2tabs after loose stool
2tabs daily
2tabs daily orally
2tabs daily orally
2tabs daily po
2tabs dly
2tabs dly p.o
2tabs p.o daily
2tabs po daily
2tabs pon
2tabs prn
2tabs tds p.o
3 mg dly
30 mgdaily
300 g daily
300 m p.o . Daily
300 m p.o daily
300 mg daily
300 mg daily orally
300 mg daily p.o.
300 mg daiy orally
300 mg dly
300 mg nocte
300 mg p-o nocte
300 mg p.o daily
300 mg prn
300mg daily
300mg dly
300mg p.o daily
300mg 1/2 tab daily
300mg 1tab p-o daily
300mg daily
300mg daily orally
300mg daily p-o
300mg daly
300mg dly
300mg dly bd
300mg dly p.o
300mg dly po
300mg nocte
300mg p-o daily
300mg p-o nocte
300mg p.o daily
300mg p.o daily
300mg po daily
300ml
31/2 tab stats 01
4 drops
4 drops twice daily p-o
4 mg 8hourly orally
4 mg PRN ( bd )
4 mg bd
4 mg prn
4 mg tds
4 mg three times daily
400 g po 3 times
400 g stat orally
400 mg 1 hourly
400 mg 6hrly orally
400 mg 8 hourlly
400 mg bd
400 mg p.o
400 mg p.o. prn
400 mg prn
400 mg shrtly orally
400 mg start
400 mg three times
400 mg/100 mg 12 hrly orally
400g p-o 8hrs
400g stat p-o
400mg p.o. stat p.o
400mg 8hrly p.o.
400mg bd
400mg p.o daily
400mg p.o prn
400mg stat
400mg stat dose
400mg 12,3mg po
400mg 6hrly
400mg 8 hrly
400mg bd
400mg dly
400mg hourly
400mg oral 6hourly
400mg oral 8hrly
400mg oral twice
400mg p-o stat
400mg p-o twice daily
400mg p.o prn
400mg sd
400mg single close
400mg start p.o.
400mg stat
400mg stat orally
400mg stat po
400mg tds /prn
400mg three times
450mg 2 tabs dly
480mg x2 daily
4gm bd
4mg tds/prn
4mg immidiately then 2mg prn
4mg 8hourly
4mg after each
4mg after each loose stool
4mg after each loose stools PRN
4mg bd
4mg bd po
4mg immediately then 2mg prn
4mg nocte
4mg prn
4mg twice
4mg,twice daily
4tabs bd po
5 mg daily
5 mg dly
5 mg orally
5 tab immidiately
50 mg stat orally
500 m 8 hourly orally
500 mg tds
500 g p.o.3 times
500 mg
500 mg p.o. three
500 mg 6 hrly
500 mg 6 hrly orally
500 mg 8 hrly
500 mg TDS
500 mg Tds
500 mg dly
500 mg orally
500 mg p.o. four times
500 mg po dly
500 mg start
500 mg start dose
500 mg stats
500 mg tds
500MG TDS
500g 8hrly
500g TDS
500g po twice
500g tds
500l 8hnrly orally
500m
500mg
500mg tds
500mg 12 hrl orally
500mg 3 times
500mg 3xdaily
500mg 6 hourly orally
500mg 6hrly
500mg 6hrly orally
500mg 6hrlyn orally
500mg 8 hrly
500mg 8hrly
500mg 8hrly orally
500mg 8wly orally
500mg TDS
500mg daily
500mg immediately
500mg immediately p.o
500mg oral stat
500mg oral twice
500mg p-o
500mg p-o 3times
500mg p-o four times
500mg p-o tds
500mg p-o twice Daily
500mg prn
500mg stat
500mg tbs
500mg tds
500mg tds p-o
500mg tds po
500mg tds prn
500mg three times daily orally
500mg twice
50g 8hrly orally
50mg dly
50mg dly
50mg tds
5m dly
5mg dly
5mg daily
5mg dly
5mg dly p.o
5mg oral daily
5mg po dly
5ml 8hrly orally
6 hourly
600 am 900 am nocte
600 mg bd
600g 8 hrly
600mg 12 hrly
600mg bd
600mg mane , 900mg
600mg mane 900mg
600mg mane 900mg nocte
600mg nocte
600mg p.o twice a day
600mg p.o twice a day
600mg, 900mg nocte
800mg 8 hourly
8hrly
900mg prn , 600mg
960 dly
960 mg o.d.
960 mg od
960 mg oral daily
960 mg po daily
960mg daily
960mg daily p-o
960mg daily p.o.
960mg daily po
960mg p.o daily
960mg p.o. daily
96mg daily
Applicant
Applied bd
Applied twice daily
Apply 1 dly
Apply 3 times
Apply Bd
Apply cream daily
Apply daily
Apply daily orally
Apply into eye tds
Apply once daily affected area
Apply once daily
Apply topically Prn
Apply twice day
Apply twice topically
I tab after each loose stool
I tab daily
I1 tab dly dly
II drops twice
II p.o. day
II tabs daily
II tabs dly p.o.
II tabs p.o. start
II tabs start then after loose stool
II tabs tabs tds p.o prn
II tabs tds p.o. prn
II tds po
Itab dly
Noccte sd per vaginal
Rub
Rub at night
Rub 3 times
Rub at night
Rub bd
Wash twice daily
applied bd
apply at night
apply bd
apply + massage
apply afafected area
apply at night
apply bd
apply daily
apply daily 1 tube
apply dly
apply nocte
apply nocte once
apply on skin
apply once daily
apply prn
apply pv nocte
apply tds
apply twice
apply twice daily
appply bd
appply twice
insert 1 tab per vaginam
insult at night
intil 1-2 drops tds
o/s
per vaginal nocte
pessory 500mg
rub 3 times
rub at night
rub bd
rub prn
tab dly
take 2tabs PRN after each loose stools
to apply
to apply twice a day
vaginal cream nocte
when necessary
Period - days covered
1440
20
999
39.169
130.999
Individual identifier
125
272
27386
12500.056
8087.036
Cluster Type (arm)
124
Control
Intervent
Sex
125
FEM
MAL
Date of birth
125
1915-04-26
1998-06-24
Start date of secondline
125
2000-07-09
2015-05-28
Number of persons HIV Positive in same Household
85
40
2
3
4
5
Sysmiss
Individual identifier
2394
272
27386
11981.761
7844.779
Cluster Type (arm)
2375
Control
Intervent
Sex
2394
FEM
MAL
Date of birth
2394
1915-04-26
1998-06-24
Start date of secondline
2394
2000-07-09
2015-05-28
Antiretroviral drug 1
2394
AZT
NAD
TDF
Unknown
d4T
ddI
Antiretroviral drug name 1
2394
Dideoxyinosine, Didanosine
Missing (iDART)
No drug
Stavudine
Tenofovir
Zidovudine
Antiretroviral drug 2
2394
3TC
FTC
NAD
Unknown
ddI
Antiretroviral drug name 2
2394
Dideoxyinosine, Didanosine
Emtricitabine
Lamivudine
Missing (iDART)
No drug
Antiretroviral drug 3
2394
ATVr
EFV
LPVr
NVP
RTV
Unknown
Antiretroviral drug name 3
2394
Atazanavir
Efavirenz
Lopinavir
Missing (iDART)
Nevirapine
Ritonavir
Antiretroviral drug 4
42
AZT
TDF
Antiretroviral drug name 4
42
Tenofovir
Zidovudine
Is regimen ATRIPLA?
2394
1
Date that regimen was
started
2394
2000-03-15
2015-11-13
Date that regimen was
stopped
66
2007-10-14
2015-08-16
Antiretroviral drug regimen
2394
AZT+3TC+EFV
AZT+3TC+LPVr
AZT+3TC+NVP
AZT+FTC+EFV
AZT+ddI+ATVr
AZT+ddI+LPVr
AZT+ddI+RTV
NAD+NAD+LPVr
TDF+3TC+ATVr
TDF+3TC+EFV
TDF+3TC+LPVr
TDF+3TC+NVP
TDF+FTC+EFV
TDF+FTC+LPVr
Unknown+Unknown+Unknown
d4T+3TC+EFV
d4T+3TC+LPVr
d4T+3TC+NVP
d4T+3TC+RTV
d4T+FTC+EFV
d4T+FTC+LPVr
ddI+3TC+LPVr
Individual identifier
136
585
26392
12812.36
7929.96
Cluster Type (arm)
135
Control
Intervent
Sex
136
FEM
MAL
Date of birth
136
1933-07-05
1996-06-18
Start date of secondline
136
2012-06-18
2015-04-16
SCI visit date
136
2012-07-04
2015-08-04
Adherence - ARV missed last
week-end
136
Miss
No
Yes
Adherence - Full daily dose
in one go (last 4 days)
136
Miss
No,
Yes,
CFU visit date
111
2012-11-06
2015-08-04
Adherence - Thinking back
over the mast 4 days, have
you missed any of your pills
111
Miss
No
Yes
Adherence - Visual Analogue
Scale (in %)
111
25
70
999
120.856
147.177
Adherence - Did the
participant reurn the pill
containers?
111
25
1
2
9
Sysmiss
Adherence - Number of pills
dispensed
111
25
32
999
410.486
381.473
Adherence - Number of pills
returned
111
25
999
310.036
440.322
Adherence - Number of pills
expected to be taken
111
25
25
999
394.712
391.095
Individual identifier
1393
272
27386
12059.093
7831.638
Cluster Type (arm)
1381
Control
Intervent
Sex
1393
FEM
MAL
Date of birth
1393
1915-04-26
1998-06-24
Start date of secondline
1393
2000-07-09
2015-05-28
Date of laboratory tests
1390
2005-01-05
2015-11-10
CD4 count from NHLS (/µL)
734
659
2
1497
296.896
220.796
ViralLoad: Viral Load (copies/mL)
1058
335
1
11000000
71708.195
454056.592
Individual identifier
125
272
27386
12594.608
7921.109
Cluster Type (arm)
124
Control
Intervent
Sex
125
FEM
MAL
Date of birth
125
1915-04-26
1998-06-24
Start date of secondline
125
2000-07-09
2015-05-28
Exit Type
38
Death
Lost to Follow-Up
No Mental Capacity
Out Migration
Transfer Out
Death - Date of death
generated from DTHVPDate
2
2014-07-09
2015-03-04
Death - Date of death as
recorded (U means unknown)
4
20140101
201407UU
20150304
Death - Immediate cause
4
Sick
natural cause
sick
wazikhunga
Death - Underlying cause
Lost to Follow-Up - Date
of LFU generated from
LFUVPDate
Lost to Follow-Up - Date of
LFU as recorded (U means
unknown)
3
20131111
20141110
20151126
Lost to Follow-Up - Reason
3
Client exited because he residing at KwaMsane
She missedvisits and she ran away from us the time we get her , she said she stopped taking tr over to the traditional medication she is taking .
She went back to Qakwini clinic for collection of ARVs
Transfer Out - Date of TFO
generated from TROVPDate
15
2012-05-01
2015-03-14
Transfer Out - Date of TFO s
recorded (U means unknown)
16
20120501
20121121
20130516
20130704
20130901
201401UU
20140206
20140416
20140901
20141105
20150126
201501UU
20150212
20150217
20150314
20150702
Transfer Out - Reason
16
He is working as security guard and allocated at Hluhluwe .
He moved to Empangeni because he found job and he lived there.
Kuthiwa usehlala ESikhawini , Ufika ngezimpelanyanga (Monthend )
Living at Mfekayi .
Out migrated Gauteng
Patient is now employed in Johannesburg , she has to locate as from today .
Relocating to Mkhuze
Sebakhe eMpangeni
She is now staying eNkonjane working there use to be at home when if she is off after that back at w
Usebenza eHluhluwe , uhlalela khona
Usebenza eGoli
Usebenza eHluhluwe ubuya monthend.
Usehlala eNquthu usebenza khona ubuya ngamaholidi .
Waya kumama wakhe useyohlala khona naye le KwaMduku
ufunda Ongoye
usebenza eGoli
Out Migration - Date of OUT
generated from OUTVPDate
9
2012-05-01
2015-03-14
Out Migration - Date of
OUT as recorded (U means
unknown)
23
20120501
201401UU
201403uu
20140901
20141105
20141120
20150126
201501UU
20150212
20150217
20150314
20150530
201505uu
20150608
20150620
201506UU
20150702
20150809
20150812
20150814
20150820
20151019
Out Migration - Reason
23
He moved to Empangeni because he found job and he lived there.
Out migrated Gauteng
Sebakhe eMpangeni
Sehlala Empangeni
She works in town and stay kwaMsane
UseGoli ngokomsebenzi
Usebenza eHluhluwe , uhlalela khona
Usebenza eHluhluwe ubuya monthend.
Usebenza eMakhakhathana ubuye month end
Usebenza ngaseMthunzini uhlala khona ufika ngokuvakasha
Usehlala eNquthu usebenza khona ubuya ngamaholidi .
Usehlala kwaMsane.
Usemsebenzini Embonambi lapho akathole khona itoho
Usethole umsebenzi kwaMsane hlala khona.
Uthi umama wakhe uhlala eDukuduku
Waya kumama wakhe useyohlala khona naye le KwaMduku
Work
ufunda Ongoye
usebenza eGoli
usebenza empangeni
usebenzela kwaMsane
uthole itoho egoli kusho udadewabo nomawakhe
uyobheka amatoho ethekwini
Notes
9
Kusho umfowabo uMathaba , Mandlakhe .
Relocated at KwaMsane.
Sehlala eMpangeni usebenza khona .
She is working at Empangeni
The client stopped tr due to the traditional medication she is taking .
The household member given the infromation of this participant working at Gauteng.
Usebenza eHluhluwe ubuya monthend.
Usehlala eGoli ngenxa yetoho .
Washona last year ngo July